Metformin Under Evaluation For Cancer Treatment

Formula Of metformin

Metformin, an oral hypoglycemic agent used as first line drug in obese type 2 diabetes is showing anticancer activity, reported by "The Lancet". It may be interesting to read.There has been possible association between obesity and different cancers. It may be possible in future to know more about action of metformin.

clipped from www.oncologystat.com Metformin Being Investigated as Possible Anticancer Treatment Elsevier Global Medical News. 2009 Oct 1, M Tucker VIENNA (EGMN) - The glucose-lowering drug metformin is increasingly showing an anticancer effect. The data come from studies being conducted in both the diabetes and oncology research communities, according to experts who spoke at the annual meeting of the European Association for the Study of Diabetes. The positive metformin story has been somewhat buried within the much broader and very complicated relationship between diabetes treatments and cancer. The subject first caught the medical community's and the general public's attention in June, with the publication of a series of articles on the putative association between insulin glargine and cancer in EASD's journal Diabetologia.

Related articles by Zemanta

• Cancer Stem cells Reduced with Diabetes Drug - Reduces Tumors (ducknetweb.blogspot.com)